|
|||||
|
|
A randomized,double-blind,phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients |
|
| Authors: | Gregory Bell Saling Huang Kevin J. Martin |
| Affiliation: | 1. Amgen, Thousand Oaks, CA, USA;2. Department of Medicine, Division of Rheumatology, University of California, San Francisco, CA, USA;3. Department of Nephrology, Saint Louis University School of Medicine, St Louis, MO, USA |
| Abstract: | |
| Keywords: | AMG 416 Calcium-sensing receptor Chronic kidney disease Hemodialysis Secondary hyperparathyroidism |